Skip to main content
Home
Toggle menu

Give Now

  • For Patients
  • School Of Medicine
  • About
    • Leadership
    • Department Directory
    • News
    • Events
    • Annual Report
    • Nashville
  • Divisions
    • Allergy, Pulmonary and Critical Care Medicine
    • Cardiovascular Medicine
    • Diabetes, Endocrinology and Metabolism
    • Epidemiology
    • Gastroenterology, Hepatology and Nutrition
    • General Internal Medicine and Public Health
    • Genetic Medicine and Clinical Pharmacology
    • Geriatric Medicine
    • Hematology and Oncology
    • Infectious Diseases
    • Nephrology and Hypertension
    • Rheumatology and Immunology
  • Education
    • Overview
    • Internal Medicine Residency Program
    • Physician-Scientist Training Program
    • Internal Medicine-Pediatrics Residency Program
    • Fellowship Programs
    • EXCellence In TEaching Pathway
    • Physician-Scientist Doctoral Program
    • Medical Students
    • Alumni
    • Medicine Grand Rounds
  • Research
    • Overview
    • Clinical Trials
    • Publications
    • Research Centers and Labs
  • Faculty
    • Open Faculty Positions
    • Professional Development
  • Clinical Initiatives
    • Digital Health
    • Physician Builder Program

User Detail

Julia Breyer Lewis, MD

Professor of Medicine

Division of Nephrology and Hypertension
Julia Breyer Lewis
Professional Bio
Julia (Breyer) Lewis, MD, is a Professor of Medicine in the Division of Nephrology and Hypertension within the Department of Medicine at Vanderbilt University Medical Center. Her area of research is the design and conduct of multi-center renal clinical trials where she has had leadership roles in numerous NIH-sponsored clinical trials including the MDRD, AASK, HEMO, pilot Diabetic Nephropathy Trial and the SPRINT Trial. In these trials, in addition to being the PI at the Vanderbilt high-enrolling and high-performing center, she has also had numerous leadership roles for the overall trial including serving on or leading the protocol design, form design, intervention, htn management, outcome classification and publication committees. Dr. Lewis has played key roles in the Collaborative Study Group (CSG), an independent ARO, sitting on its executive committee for over 20 years in charge of protocol development. She has served as president of the CSG, and its coordinating center and all its central activities have transferred to Vanderbilt. The CSG has been responsible for key clinical trials in nephrology including ones leading to FDA approval of captopril and irbesartan for diabetic nephropathy and ferric citrate as a phosphate binder for dialysis patients. Dr. Lewis serves as head of several NIH and industry sponsored oversight/advisory panels. She has completed a term as a member of the cardio-renal FDA Advisory Board as well as chair of the cardio-renal panel and currently has been asked to serve a second term as chair. She has over 200 publications in peer-approved journals and has served as the nephrology fellowship director for over 25 years.
Relevant Links
Provider Profile
Publications
View Publications

Education

MD - University of Illinois at Urbana-Champaign, 1980

Internship - Michael Reese Hospital, 1983

Residency - Michael Reese Hospital, 1983

Fellowship - Nephrology - University of Texas Health Science Center at Houston, 1985

Fellowship - Nephrology - Vanderbilt University, 1986

Contact

Email 
Kimryn.Rathmell@Vumc.Org 
Address 
777 Preston Research Building 
2220 Pierce Ave 
Nashville, TN 37232-6307

Submitted by admin on Thu, 06/01/2023 - 04:28

1161 21st Ave S
Nashville, TN 37232

(615) 322-5000

Quick Links

  • Home
  • About
  • Divisions
  • Education
  • Research
  • Faculty
  • Intranet

Support Our Work

Start a fundraiser or donate to the Department of Medicine.

Give Now

Vanderbilt Health is committed to fostering an environment where everyone has the chance to thrive and is committed to the principles of equal opportunity. EOE/Vets/Disabled.

Copyright © Vanderbilt University Medical Center

sfy39587stp18